JonSnow
Intermediate
Join Date: 8.11.2018
Posts: 82
|
|
|
Posted: 8.11.2018 2:53:03
|
|
|
Clinical Trials Experience. Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
Table 3 lists adverse reactions that occurred in at least 1% of best price neurontin -treated patients with postherpetic neuralgia participating in placebo-controlled trials and that were numerically more frequent in the best price neurontin group than in the placebo group.
Antiepileptic drugs (AEDs), including best price neurontin , increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication. Patients treated with any AED for any indication should be monitored for the emergence or worsening of depression, suicidal thoughts or behavior, and/or any unusual changes in mood or behavior.
Moreover, because neurontin causes somnolence and dizziness [see Somnolence/Sedation And Dizziness], patients should be advised not to operate complex machinery until they have gained sufficient experience on neurontin to assess whether neurontin impairs their ability to perform such tasks.
Some of these could represent seizure-related deaths in which the seizure was not observed, e.g., at night. This represents an incidence of 0.0038 deaths per patient-year. Although this rate exceeds that expected in a healthy population matched for age and sex, it is within the range of estimates for the incidence of sudden unexplained deaths in patients with epilepsy not receiving neurontin (ranging from 0.0005 for the general population of epileptics to 0.003 for a clinical trial population similar to that in the neurontin program, to 0.005 for patients with refractory epilepsy). Consequently, whether these figures are reassuring or raise further concern depends on comparability of the populations reported upon to the neurontin cohort and the accuracy of the estimates provided.
neurontin is available as capsules as 100, 300, and 400 mg; tablets as 100, 300, 400, 600, and 800 mg; and as a solution of 250 mg/5 ml. The exact dosage depends upon the condition being treated. It is not known if this drug is safe to take during pregnancy. It is secreted in breast milk, so mothers who are breastfeeding should consult their OB/GYN or other health care professional and only use this neurontin if the benefits outweigh the risks to the fetus. neurontin is not a narcotic (opioid), however, it does share signs and symptoms associated with drug abuse and addiction. Patients taking this drug may experience withdrawal symptoms like goosebumps, sweating, vomiting, and nausea. neurontin was approved by the FDA in 1993.
neurontin was administered orally to mice and rats in 2-year carcinogenicity studies. No evidence of drug-related carcinogenicity was observed in mice treated at doses up to 2000 mg/kg/day. At 2000 mg/kg, the plasma neurontin exposure (AUC) in mice is approximately 2 times that in humans at the MRHD of 3600 mg/day. In rats, increases in the incidence of pancreatic acinar cell adenoma and carcinoma were found in male rats receiving the highest dose (2000 mg/kg), but not at doses of 250 or 1000 mg/kg/day. At 1000 mg/kg, the plasma neurontin exposure (AUC) in rats is approximately 5 times that in humans at the MRHD.
What else should I know about this drug? What is neurontin, and how does it work (mechanism of action)neurontin is an anti-seizure (anti-convulsant) drug that is used for preventing seizures and for treating post-herpetic neuralgia, the pain that follows an episode of shingles.Doctors do not know how neurontin works (the mechanism of action). neurontin structurally resembles the neurotransmitter gamma aminobutyric acid (GABA). (Neurotransmitters are drugs that nerves use to communicate with one another.) It is possible that this similarity is related to neurontin''s mechanism of action. In animal models used for testing the anticonvulsant and analgesic (anti-pain) activities of drugs, neurontin prevents seizures and reduces pain-related responses.
When pregnant rabbits were treated with neurontin during the period of organogenesis, an increase in embryo-fetal mortality was observed at all doses tested (60, 300, or 1500 mg/kg). The lowest effect dose for embryo-fetal developmental toxicity in rabbits is less than the MRHD on a mg/m? basis.
|
|